What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Health care
His primary scientific interests are in Internal medicine, Surgery, Cancer, Intensive care medicine and Randomized controlled trial.
His work on Internal medicine is being expanded to include thematically relevant topics such as Oncology.
The various areas that Scott D. Ramsey examines in his Surgery study include Diabetes mellitus, Demography, Incidence and Risk factor.
His Cancer study combines topics from a wide range of disciplines, such as Gerontology and Family medicine.
His biological study spans a wide range of topics, including MEDLINE, Regimen, Guideline, Lung and Public health.
His research in Randomized controlled trial intersects with topics in Anesthesia, Thoracoscopy, Lung volume reduction surgery, Video assisted thoracic surgery and Physical therapy.
His most cited work include:
- Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability (2320 citations)
- Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial (1053 citations)
- THE CASE FOR EARLY DETECTION (907 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Oncology, Cancer, Clinical trial and Intensive care medicine.
His research on Internal medicine frequently connects to adjacent areas such as Surgery.
As a member of one scientific family, Scott D. Ramsey mostly works in the field of Oncology, focusing on Prostate cancer and, on occasion, Gynecology.
He has included themes like Epidemiology, Disease, Gerontology and Family medicine in his Cancer study.
His work focuses on many connections between Clinical trial and other disciplines, such as Randomized controlled trial, that overlap with his field of interest in Physical therapy.
His Intensive care medicine study integrates concerns from other disciplines, such as Health care and MEDLINE.
He most often published in these fields:
- Internal medicine (49.85%)
- Oncology (35.41%)
- Cancer (34.35%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (49.85%)
- Cancer (34.35%)
- Oncology (35.41%)
In recent papers he was focusing on the following fields of study:
Scott D. Ramsey spends much of his time researching Internal medicine, Cancer, Oncology, Clinical trial and Breast cancer.
His Cancer research incorporates elements of Lung cancer, Health care and Family medicine.
His work deals with themes such as Epidermal growth factor receptor and Intensive care medicine, which intersect with Lung cancer.
His research integrates issues of Genetic testing, Long term survival, Triple-negative breast cancer and MEDLINE in his study of Oncology.
The study incorporates disciplines such as Biomarker, Socioeconomic status, Survival analysis and non-small cell lung cancer in addition to Clinical trial.
The concepts of his Breast cancer study are interwoven with issues in Stage, Randomized controlled trial, Tumor marker and Asymptomatic.
Between 2016 and 2021, his most popular works were:
- Association between Body Mass Index and Cancer Survival in a Pooled Analysis of 22 Clinical Trials (66 citations)
- A Health Economics Approach to US Value Assessment Frameworks—Summary and Recommendations of the ISPOR Special Task Force Report [7] (64 citations)
- Pilot Feasibility Study of an Oncology Financial Navigation Program. (48 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Health care
His scientific interests lie mostly in Internal medicine, Oncology, Cancer, Clinical trial and Breast cancer.
His Internal medicine study focuses mostly on Carcinoma, Disease, Chemotherapy, Randomized controlled trial and Confidence interval.
His Oncology study combines topics in areas such as Quality-adjusted life year, MEDLINE, Genetic testing and Prostate cancer.
His study in Cancer is interdisciplinary in nature, drawing from both Hepatitis B, Hepatitis C virus, Young adult, Demography and Cost-effectiveness analysis.
His Clinical trial research is multidisciplinary, relying on both Inclusion, Cohort study, Proportional hazards model, Survival analysis and Cohort.
His Breast cancer study incorporates themes from Stage and Logistic regression.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
